Bryxta 300 Injection Substitute
Cizumab 300 Injection 12 ml
by Others
₹1491.67per tabletBevatas 300 Injection 12 ml
by Others
₹1230.00per tabletBevatas 300mg Solution for Infusion
by Others
₹1230.00per tablet
Verified Ingredients and Effects
Composition:
BEVACIZUMAB-300MG
Uses:
Treatment of Metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum
Medicinal Benefits:
Bryxta 300 Injection contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Bryxta 300 Injection works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.
FAQs
Bryxta 300 Injection is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum.
Bryxta 300 Injection works against a protein called vascular endothelial growth factor (VEGF). Inhibition of vascular endothelial growth factor (VEGF) limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thereby, Bryxta 300 Injection helps treat cancer.
Bryxta 300 Injection may reduce the number of red blood cells leading to anaemia. Its symptoms include pale skin, lack of energy, feeling breathless, feeling dizzy and lightheadedness.
Chemotherapy remains necessary. Bryxta 300 Injection is given along with chemotherapy for treating cancer.
Bryxta 300 Injection may increase the risk of bleeding and problems with wound healing. If you have had major surgery in the past 28days or if the wound hasn't healed, you should not take Bryxta 300 Injection. Talk to your doctor for more information.
Cancer can affect anyone, though the risk increases with age. Individual risk is determined by factors such as smoking and drinking habits, lifestyle choices such as what you eat and exercise; a family history of cancer, and factors in your workplace and environment.
Bryxta 300 Injection may increase the incidence of hypertension. Therefore, consult your doctor before taking Bryxta 300 Injection if you have high blood pressure.
Bryxta 300 Injection is given intravenously (into a vein) infusion by a healthcare professional. Bryxta 300 Injection should never be given as an intravenous push or bolus. Do not self-administer.
The duration of treatment with Bryxta 300 Injection depends on your condition and response to the treatment. Your doctor will decide the length of time, based on its effectiveness and your tolerance. Regular monitoring will guide ongoing treatment.
Chemotherapy targets and destroys rapidly dividing cells, including cancer cells, to stop their growth and spread. While, Bryxta 300 Injection works by inhibiting the formation of new blood vessels that supply oxygen and nutrients to tumors. Cutting off this blood supply helps shrink the tumor or prevent it from growing further.
A person taking Bryxta 300 Injection may still require chemotherapy. Bryxta 300 Injection is often used in combination with chemotherapy to treat certain cancers, as it helps prevent tumor growth by blocking blood vessel formation and improves the effectiveness of chemotherapy.
Bryxta 300 Injection causes side effects such as constipation, loss of appetite, fever, nose bleeds, change in speech, voice changes/hoarseness, and loss of body weight. Most of these side effects do not require any medical requirements as they will gradually reduce over time. Contact a doctor if these side effects persist for longer durations.